Get started
Author

Jovita K. Byemerwa

Observed names: Byemerwa, J, Jovita Byemerwa, Jovita K Byemerwa, Jovita Kokwesiga Byemerwa
ORCID: 0000-0002-8028-9603
Observed ORCID: 0000-0002-8028-9603
OpenAlex ID: A5088748997
Estrogen Receptor Signaling in the Immune System
2022 · Binita Chakraborty, Jovita Byemerwa, et al. · Endocrine Reviews · 265
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma
2021 · Binita Chakraborty, Jovita Byemerwa, et al. · Journal of Clinical Investigation · 122
PDF
Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding
2018 · Hou-Fu Guo, Chi-Lin Tsai, et al. · Nature Communications · 52
PDF
Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models
2020 · Katherine M. Deland, Bryce F. Starr, et al. · Journal of Clinical Investigation · 43
PDF
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth
2024 · Sandeep Artham, Patrick K. Juras, et al. · Science Advances · 29
UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology
2023 · Meghan J. Price, Annee D. Nguyen, et al. · Oncotarget · 25
PDF
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens
2025 · Jovita Byemerwa, Ching-Yi Chang, et al. · Endocrine Reviews · 10
A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3- d ]pyrimidine Core
2022 · Vamshikrishna Reddy Sammeta, John D. Norris, et al. · ACS Medicinal Chemistry Letters · 3
PDF
Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironment
2024 · Binita Chakraborty, Prabuddha Chakraborty, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Abstract B06: 17β-estradiol negatively regulates natural killer cells and promotes breast cancer metastasis
2022 · Jovita K Byemerwa, Aditi Goyal, et al. · Cancer Immunology Research · 1
Estrogen promotes tumor phenotypes in ER+ and ER– breast cancer through UGDH-GPR30
2026 · Meghan J. Price, Annee D. Nguyen, et al. · JCI Insight
Association of tumor-infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: analysis of the MEND study
2026 · Jovita Byemerwa, Drew Neish, et al. · Breast Cancer Research and Treatment
Association of cumulative lifetime estrogen exposure and reproductive factors with breast cancer molecular subtype among Nigerian women in the MEND study
2026 · Jovita Byemerwa, Drew Neish, et al. · Breast Cancer Research and Treatment
Abstract 7866: BMI- and subtype-specific molecular clusters reveal distinct obesity mechanisms in breast cancer across Nigerian and U.S. cohorts.
2026 · Oyomoare Osazuwa-Peters, Jovita Kokwesiga Byemerwa, et al. · Cancer Research
Abstract 6263: Association of tumor infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: Analysis of the MEND study.
2026 · Jovita Byemerwa, Drew Neish, et al. · Cancer Research
Abstract 7360: Characterizing the immune microenvironment of Nigerian breast tumors by subtype
2025 · Jovita Byemerwa, Drew Neish, et al. · Cancer Research
Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma
2024 · Chang, C.-Y, Mukherjee, D, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
UDP-6-glucose dehydrogenase in hormonally responsive breast cancers
2024 · Meghan J. Price, Annee D. Nguyen, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract B02: Estrogens regulate tumor associated tissue eosinophilia to promote tumor growth
2022 · Sandeep Artham, Aditi Goyal, et al. · Cancer Immunology Research
Abstract P131: The role of UDP-6 glucose dehydrogenase (UGDH) in estrogen-mediated phenotypes in both estrogen receptor positive and estrogen receptor negative breast cancer
2021 · Meghan Price, Catherine Lavau, et al. · Molecular Cancer Therapeutics
Works count: 20
Citation count: 552
H-index: 7
I10-index: 7
Year
Topic
Type